Poland - Pharmaceutical products

Description

The subject of the contract is the purchase and delivery of medicines from drug programmes. A detailed description of the subject matter of the contract is contained in Volume III of the SWZ (Terms of Reference). The offered medicinal products must be entered in the Official List of Pharmaceuticals and Medical Supplies allowed for marketing in Poland.
Medicines in the drug programme - TREATMENT OF CANCER RESISTANT TO CANCER TREATMENT OF STEPHOROPOULAR CANCER Medicines in the drug programme - TREATMENT OF CANCER RESISTANT TO CANCER MEDICATION OF NON-SMALL CELLULAR CANCER WITH AFATINIB Medication in the drug- treatment programme Treatment of neovascular age-related macular degeneration (AMD) Treatment of Gastrointestinal Cancer Drug in the Medication Program - Treatment of Non-Small Cell Lung Cancer Drug in the Medication Program - Treatment of Familial Hypercholesterolemia Drug in the Medication Program - Treatment of Non-Small Cell Lung Cancer Drug in the Medication Program - Treatment of Renal Cell Carcinoma Drug in the Medication Program - Treatment of Advanced Ovarian Cancer, 0) AND SERIOUS EOSINPHILIC ASTMA Drug in the Medication Program - STRICT LIMFOBLASTIC LEAKAGE Drug in the Medication Program -Treatment of Pulmonary Arterial Hypertension (PAH) Drug in the Medication Program -Treatment of Transient SICKLE LEAKAGE Drug in the Medication Program -Treatment of Refractory and Recurrent Stages of CD30+ Lymphoma, MEDICINAL PROGRAMME - MEDICINAL PROGRAMME - MEDICINAL PROGRAMME - TREATMENT OF RESISTANT OR RECURRENT PLASMOCTIC TROUBLE CANCER (ICD-10 C 34) MEDICINAL PROGRAMME - MEDICINAL PROGRAMME - MEDICINAL PROGRAMME - TREATMENT OF RESISTANT OR RECURRENT PLASMOCTIC TROUBLE CANCER Treatment of pulmonary arterial hypertension Medicines in the Medication Program - Treatment of non-small cell lung cancer Medicines in the Medication Program - Treatment of familial hypercholesterolemia Medicines in the Medication Program - Treatment of non-small cell lung cancer IBRUTYNIB IN THE MEDICATION OF CURRENT LIMFOCYTIC LEAKAGE Drug in the Medication Program - TREATMENT OF PAIN-Hypertension (TNP) MEDICATION FOR Gastrointestinal Tract Tumors (GIST) Medication in the Medication Program - MEDICATION FOR PRIMARY IMMUNE DEFICIENCY (PID) IN ADULTS MEDICATION OF RESISTANT OR RECURRENT PLASMOCYTIC TISSUE A drug in the drug program - TREATMENT OF BREAST CANCER A drug in the drug program - - LENALIDOMIDE LENALIDOMIDE IN THE TREATMENT OF RESISTANT OR RECURRENT MUNICAN TREATMENT OF RESISTANT OR RECURRENT MUNICAN TREATMENT OF PAIN PAIN PRESSURE (TNP) Drug in the Medication Program - MEDICATION OF SERIOUS IGE-Dependent ALLERGIC ASTMA (ICD-10 J 45.0) AND SERIOUS EOSINPHILIC ASTMA Medicinal product in the drug programme - TREATMENT OF PATIENTS WITH ARRESTIVE SHAPE LEAKAGE Medicinal product in the drug programme - TREATMENT OF TRANSLATED SHAPE LEAKAGE IDIOPATHIC LUNG BLOOD CANCER MEDICINE IN THE MEDICATION PROGRAM - MEDICATION OF NON-SMALL CELLULAR CANCER WITH AFATINIB AND NINTEDANIB Treatment of non-small cell lung cancer Treatment of renal cell carcinoma Treatment of refractory and relapsed CLASSIC HODGkin's lymphoma with NIVOLUMABTreatment of Chronic Leukemia LIMFOCYTE WITH OBINUTUZUMAB Drug in the Medication Program - OLAPARIB SUBTRACTIVE TREATMENT OF NAVARIOUS PLATINUM CARCINOGEN CARCASES, Ovarian Cancer, or Primary Ovarian Cancer Drugs in the drug program - TREATMENT OF HEAVY ALERGENIC ASTMA IGE DUE TO OMALYSUMAB, Treatment of IDIOPATHIC LUNG BLOOD DISEASE Drug in the Medication Program -PIKSANTRON IN THE TREATMENT OF CELLULOMAGNOSMERS Drug in the Medication Program -TREATMENT OF RESISTANT OR RECURRENT MUNICIPAL AMYSTEMS Drug in the Medication Program -TREATMENT OF PATIENTS WITH TRANSLUCTIVE SLAYMAKER, TREATMENT OF PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA. Treatment of neovascular age-related macular degeneration (AMD), PRIMARY MYELOFIBROSIS AND CONTRIBUTIVE MYELOFIBROSIS IN THE PERIPHERENCE OF PRIMARY MERRENCY AND SELF-INFLAMMATION Drugs in the drug program - TREATMENT OF PAIN PAIN PRESSURE (TNP) Drugs in the drug program - TREATMENT OF PAIN PAIN PAIN PRESSURE Drugs in the drug program - TREATMENT OF NERVE CANCER , MEDICINE IN THE MEDICINAL PROGRAM TREATMENT OF Gastrointestinal Stem Cell Carcinoma (GIST), ADVANCED GERRONAL CANCER TREATMENT Drug in the drug program - TREATMENT OF BREAST CANCER Drugs in the drug program - TREATMENT OF BREAST CANCER Drugs in the drug program - TREATMENT OF PAIN PAIN PRESSURE Drugs in the drug program - TREATMENT OF PAIN PAIN PRESSURE MEDICATION FOR ADVANCED GERROGEAL CANCER Possibility of DOSE-Swapping as part of a Medication Package - MEDICATION FOR PRECURRENT LIMFOCYTIC LEAKAGE PATIENTS WITH VENETOXICLAX OR VENETOXICLAX CONCOMBINED WITH RITUXYMAB MEDICATIONS IN THE MEDICINAL PROGRAM - MEDICATIONS IN THE MEDICINAL PROGRAM - MEDICINES IN THE MEDICINAL PROGRAM - MEDICINES IN THE MEDICINAL PROGRAM - MEDICINES IN THE MEDICINAL PROGRAM - MEDICINES IN THE MEDICINAL PROGRAM - MEDICINES IN THE MEDICINAL PROGRAM - MEDICINES IN THE MEDICINAL PROGRAM - MEDICINES IN THE MEDICINAL PROGRAM - MEDICINES IN THE MEDICINAL PROGRAM - MEDICINATION OF NON-SMALL CELLULAR OR SMALL CELLULAR CANCER

Opportunity closing date

28 January 2022

Value of contract

to be confirmed